Abstract
ABSTRACT
Background: Schizophrenia is a complex, debilitating disorder imposing a substantial global burden. Its symptomatic heterogeneity has prompted a shift from traditional subtypes towards a dimensional understanding, validating the positive-negative dichotomy as two core domains with divergent neurobiological substrates. While this structure is established, the specific clinical, functional, and sociodemographic factors modulating each domain's severity can vary across populations. In Vietnam, despite schizophrenia being a significant public health concern, a critical gap exists. There is a lack of comprehensive investigations concurrently examining a broad range of predictors for both symptom domains in an inpatient setting.
Objectives: To identify factors independently associated with the severity of positive and negative symptoms among inpatients with schizophrenia in Vietnam.
Materials and methods: A cross-sectional study was conducted with 121 inpatients (ICD-10 diagnosis) at Hue Psychiatric Hospital from September 2024 to April 2025. Data were collected on sociodemographic, clinical, and functional characteristics. Symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS). Cognitive and social functioning were measured with the Mini-Mental State Examination (MMSE) and Social Functioning Questionnaire (SFQ), respectively. Two separate multiple linear regression models were constructed to identify independent predictors for PANSS positive and negative subscale scores.
Results: The model for positive symptoms (R² = .305, p < .001) found higher severity was independently associated with the Paranoid (F20.0) subtype (vs. Undifferentiated and Other subtypes) and antipsychotic polypharmacy (≥ 3 medications). The model for negative symptoms (R² = .496, p < .001) identified a different set of predictors. Higher negative symptom severity was independently associated with lower cognitive (MMSE) scores, poorer social functioning (SFQ ≥ 10), and female gender.
Conclusion: The determinants of positive and negative symptoms in schizophrenia are markedly distinct. Positive symptoms were primarily associated with clinical-diagnostic features and treatment complexity, while negative symptoms were strongly linked to cognitive and functional impairments. These findings highlight the need for personalized, dimension-specific therapeutic strategies to improve patient outcomes in Vietnam.
Keywords: Schizophrenia; Positive symptoms; Negative symptoms; Cognitive dysfunction; Social functioning.
| Published | 2026-04-30 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 16 No. 02 (2026) | |
| Section | Original Articles | |
| DOI | 10.34071/jmp.2026.2.780 | |
| Keywords | schizophrenia, Positive symptoms, Negative symptoms, Cognitive dysfunction, Social functioning |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Hue Journal of Medicine and Pharmacy
Anwar A, Mustafa AM, Abdou K, M AR, El-Shiekh RA, El-Dessouki AM. A comprehensive review on schizophrenia: epidemiology, pathogenesis, diagnosis, conventional treatments, and proposed natural compounds used for management. Naunyn Schmiedebergs Arch Pharmacol. 2025.
Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019. Mol Psychiatry. 2023;28(12):5319-27.
Luvsannyam E, Jain MS, Pormento MKL, Siddiqui H, Balagtas ARA, Emuze BO, et al. Neurobiology of Schizophrenia: A Comprehensive Review. Cureus. 2022;14(4):e23959.
Chen J, Patil KR, Weis S, Sim K, Nickl-Jockschat T, Zhou J, et al. Neurobiological Divergence of the Positive and Negative Schizophrenia Subtypes Identified on a New Factor Structure of Psychopathology Using Non-negative Factorization: An International Machine Learning Study. Biol Psychiatry. 2020;87(3):282-93.
Nguyễn Văn Siêm. Nghiên cứu dịch tễ lâm sàng bệnh tâm thần phân liệt tại cộng đồng. Y học thực hành. 2010;2010(2):705.
Đạt BX, Tuấn NV, Anh HVT, Giang NT. Đặc điểm lâm sàng rối loạn hoạt động có ý chí ở người bệnh tâm thần phân liệt tại Viện Sức khoẻ tâm thần Quốc gia. Tạp chí Y học Việt Nam. 2025;553(1).
Đỗ XT, Đinh TH, Bùi QH. Nghiên cứu kết quả điều trị bệnh nhân tâm thần phân liệt có và không có triệu chứng âm tính bằng olanzapine. Tạp chí Y học Việt Nam. 2022;519(2).
Trần TTH, Nguyễn VT, Nguyễn HY, Đoàn TH, Nguyễn MH. Thiếu hiểu biết bản thân ở người bệnh tâm thần phân liệt thể paranoid. Tạp chí Y học Việt Nam. 2021;507(1).
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia bulletin. 1987;13(2):261-76.
Lim K, Peh O-H, Yang Z, Rekhi G, Rapisarda A, See Y-M, et al. Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia. Asian Journal of Psychiatry. 2021;62:102732.
Geck S, Roithmeier M, Bühner M, Wehr S, Weigel L, Priller J, et al. COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS). EClinicalMedicine. 2025;82.
Tyrer P, Nur U, Crawford M, Karlsen S, MacLean C, Rao B, et al. The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning. International Journal of Social Psychiatry. 2005;51(3):265-75.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research. 1975;12(3):189-98.
Tombaugh TN, McIntyre NJ. The mini‐mental state examination: a comprehensive review. Journal of the American Geriatrics Society. 1992;40(9):922-35.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines: World Health Organization; 1992.
Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophrenia bulletin. 2006;32(2):250-8.
Kaneko K. Negative symptoms and cognitive impairments in schizophrenia: two key symptoms negatively influencing social functioning. Yonago acta medica. 2018;61(2):091-102.
O'Leary DS, Flaum M, Kesler ML, Flashman LA, Arndt S, Andreasen NC. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. The Journal of neuropsychiatry and clinical neurosciences. 2000;12(1):4-15.
Kim J-J, Pae C-U, Han C, Bahk W-M, Lee S-J, Patkar AA, et al. Exploring hidden issues in the use of antipsychotic polypharmacy in the treatment of schizophrenia. Clinical Psychopharmacology and Neuroscience. 2021;19(4):600.
van Bennekom MWL, IntHout J, Gijsman HJ, Akdede BB, Yağcıoğlu AEA, Barnes TR, et al. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data. Schizophrenia Research. 2024;272:1-11.
Wang Z, Ling Y, Wang Y, Zhu T, Gao J, Tang X, et al. The role of two factors of negative symptoms and cognition on social functioning in male patients with Schizophrenia: a Mediator Model. Brain Sciences. 2023;13(2):187.
Khantzian EJ. The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard review of psychiatry. 1997;4(5):231-44.